Percentage of biological materials (and biofuels used for non-energy purposes) used to manufacture products and services (including packaging) that is sustainably sourced

Unit

: Percentage (%)

Indicator

: Resource consumption

Metric type

: Pressure

Framework alignment notes

Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry for alignment to the metric

WHO Guidance

GBF Target 7

Target example
i

An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.

[Company name] will increase the percentage of biological materials used to manufacture products and services that are sustainably sourced by [target amount]% by [target year], compared to a [baseline year] baseline

Target source: WBCSD target template

Sector

Pharmaceutical

Value chain stage

Raw Materials Manufacturing End of Life

Metric assessment

Relevance: High

Feasibility: Low

Related actions

Use recycled, renewable, or biodegradable materials to reduce reliance on virgin and fossil-based resources

Reduce operational waste through improved material efficiency and reuse

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

What's new

Advancing an integrated sustainability agenda to unlock business value

India Landscape Accelerator Kickoff: From Pilots to Landscape-Scale Impact

Comparing Physical Risk: Global Trends vs. Asia-Pacific Realities

Percentage of biological materials (and biofuels used for non-energy purposes) used to manufacture products and services (including packaging) that is sustainably sourced

Framework alignment notes

Target example
i

An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.

Sector

Value chain stage

Metric assessment

Related actions

Use recycled, renewable, or biodegradable materials to reduce reliance on virgin and fossil-based resources

Reduce operational waste through improved material efficiency and reuse

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Design processes and products to minimize waste and maximize circularity

Engage and collaborate with suppliers to adopt innovative, sustainable, and circular materials and solutions

What's new

Advancing an integrated sustainability agenda to unlock business value

India Landscape Accelerator Kickoff: From Pilots to Landscape-Scale Impact

Comparing Physical Risk: Global Trends vs. Asia-Pacific Realities

Percentage of biological materials (and biofuels used for non-energy purposes) used to manufacture products and services (including packaging) that is sustainably sourced

Framework alignment notes

Target example i An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.

Sector

Value chain stage

Metric assessment

Related actions

Use recycled, renewable, or biodegradable materials to reduce reliance on virgin and fossil-based resources

Reduce operational waste through improved material efficiency and reuse

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Design processes and products to minimize waste and maximize circularity

Engage and collaborate with suppliers to adopt innovative, sustainable, and circular materials and solutions

Target example
i

An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.